Virbac (VRBCF) Stock Price, News & Analysis

Company Overview

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Key Stats

• Today's Range: $346.00 to $346.00
• 50-Day Range: $346.00 to $346.00
• 52-Week Range: $324.00 to $383.52
• Volume: N/A
• Average Volume: 100 shs
• Market Capitalization: N/A
• P/E Ratio: 52.32
• Dividend Yield: 0.55%
• Price Target: N/A
• Consensus Rating: N/A

VRBCF Stock Analysis - Frequently Asked Questions

How have VRBCF shares performed this year?

Virbac's stock was trading at $339.23 at the beginning of 2025. Since then, VRBCF shares have increased by 2.0% and is now trading at $346.00.

How do I buy shares of Virbac?

Shares of VRBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTC
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: N/A
• Current Symbol: OTC:VRBCF
• CIK: 2029969
• Web: www.virbac.fr
• Phone: 33.4.92.08.71.00
• Fax: N/A
• Employees: 5,459
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 52.32
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A